These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28127947)

  • 1. Recommended approaches to the scientific evaluation of ecotoxicological hazards and risks of endocrine-active substances.
    Matthiessen P; Ankley GT; Biever RC; Bjerregaard P; Borgert C; Brugger K; Blankinship A; Chambers J; Coady KK; Constantine L; Dang Z; Denslow ND; Dreier DA; Dungey S; Gray LE; Gross M; Guiney PD; Hecker M; Holbech H; Iguchi T; Kadlec S; Karouna-Renier NK; Katsiadaki I; Kawashima Y; Kloas W; Krueger H; Kumar A; Lagadic L; Leopold A; Levine SL; Maack G; Marty S; Meador J; Mihaich E; Odum J; Ortego L; Parrott J; Pickford D; Roberts M; Schaefers C; Schwarz T; Solomon K; Verslycke T; Weltje L; Wheeler JR; Williams M; Wolf JC; Yamazaki K
    Integr Environ Assess Manag; 2017 Mar; 13(2):267-279. PubMed ID: 28127947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecotoxicological hazard and risk assessment of endocrine active substances.
    Leopold A; Roberts M; Matthiessen P
    Integr Environ Assess Manag; 2017 Mar; 13(2):264-266. PubMed ID: 27862919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-relevant endpoints in the evaluation of endocrine-active substances (EAS) for ecotoxicological hazard and risk assessment.
    Marty MS; Blankinship A; Chambers J; Constantine L; Kloas W; Kumar A; Lagadic L; Meador J; Pickford D; Schwarz T; Verslycke T
    Integr Environ Assess Manag; 2017 Mar; 13(2):317-330. PubMed ID: 28052490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncertainties in biological responses that influence hazard and risk approaches to the regulation of endocrine active substances.
    Parrott JL; Bjerregaard P; Brugger KE; Gray LE; Iguchi T; Kadlec SM; Weltje L; Wheeler JR
    Integr Environ Assess Manag; 2017 Mar; 13(2):293-301. PubMed ID: 27862884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.
    Coady KK; Biever RC; Denslow ND; Gross M; Guiney PD; Holbech H; Karouna-Renier NK; Katsiadaki I; Krueger H; Levine SL; Maack G; Williams M; Wolf JC; Ankley GT
    Integr Environ Assess Manag; 2017 Mar; 13(2):302-316. PubMed ID: 27791330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the relevance of ecotoxicological studies for regulatory decision making.
    Rudén C; Adams J; Ågerstrand M; Brock TC; Poulsen V; Schlekat CE; Wheeler JR; Henry TR
    Integr Environ Assess Manag; 2017 Jul; 13(4):652-663. PubMed ID: 27599457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating endocrine-disrupting properties of chemicals in fish and amphibians: Opportunities to apply the 3Rs.
    Burden N; Embry MR; Hutchinson TH; Lynn SG; Maynard SK; Mitchell CA; Pellizzato F; Sewell F; Thorpe KL; Weltje L; Wheeler JR
    Integr Environ Assess Manag; 2022 Mar; 18(2):442-458. PubMed ID: 34292658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approach to weight-of-evidence assessment of ecotoxicological effects in regulatory decision-making.
    Hall AT; Belanger SE; Guiney PD; Galay-Burgos M; Maack G; Stubblefield W; Martin O
    Integr Environ Assess Manag; 2017 Jul; 13(4):573-579. PubMed ID: 28383801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the population relevance of endocrine-disrupting effects for nontarget vertebrates exposed to plant protection products.
    Crane M; Hallmark N; Lagadic L; Ott K; Pickford D; Preuss T; Thompson H; Thorbek P; Weltje L; Wheeler JR
    Integr Environ Assess Manag; 2019 Mar; 15(2):278-291. PubMed ID: 30520244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary exposure to endocrine-active pesticides: Conflicting opinions in a European workshop.
    Flynn K
    Environ Int; 2011 Jul; 37(5):980-90. PubMed ID: 21497907
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of and Challenges in Regulating Endocrine Disruptors - How Regulators and Industry Can Conquer?
    Dhiman SK; Dureja H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1664-1681. PubMed ID: 32504507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the credibility of histopathology data in environmental endocrine toxicity studies.
    Wolf JC; Maack G
    Environ Toxicol Chem; 2017 Mar; 36(3):601-611. PubMed ID: 27883231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative screening-level approach to incorporate chemical exposure and risk into alternative assessment evaluations.
    Arnold SM; Greggs B; Goyak KO; Landenberger BD; Mason AM; Howard B; Zaleski RT
    Integr Environ Assess Manag; 2017 Nov; 13(6):1007-1022. PubMed ID: 28294522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating climate change model projections into ecological risk assessments to help inform risk management and adaptation strategies: Synthesis of a SETAC Pellston Workshop®.
    Stahl RG; Boxall ABA; Brix KV; Landis WG; Stauber JL; Moe SJ
    Integr Environ Assess Manag; 2024 Mar; 20(2):359-366. PubMed ID: 38124219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a proportionality assessment of risk reduction measures aimed at restricting the use of persistent and bioaccumulative substances.
    Oosterhuis F; Brouwer R; Janssen M; Verhoeven J; Luttikhuizen C
    Integr Environ Assess Manag; 2017 Nov; 13(6):1100-1112. PubMed ID: 28548694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the reliability of ecotoxicological studies: An overview of current needs and approaches.
    Moermond C; Beasley A; Breton R; Junghans M; Laskowski R; Solomon K; Zahner H
    Integr Environ Assess Manag; 2017 Jul; 13(4):640-651. PubMed ID: 27869364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Union regulators and industry agree on improving specific environmental release categories: Report from the exchange network for exposure scenarios specific environmental release category workshop on May 13, 2016.
    Ahrens A; Moilanen M; Martin S; Garcia-John E; Sättler D; Bakker J; Reihlen A; Wind T; Tolls J
    Integr Environ Assess Manag; 2017 Sep; 13(5):815-820. PubMed ID: 28121063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward sustainable environmental quality: Identifying priority research questions for Latin America.
    Furley TH; Brodeur J; Silva de Assis HC; Carriquiriborde P; Chagas KR; Corrales J; Denadai M; Fuchs J; Mascarenhas R; Miglioranza KS; Miguez Caramés DM; Navas JM; Nugegoda D; Planes E; Rodriguez-Jorquera IA; Orozco-Medina M; Boxall AB; Rudd MA; Brooks BW
    Integr Environ Assess Manag; 2018 May; 14(3):344-357. PubMed ID: 29469193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.
    Fegert I
    Toxicol Lett; 2013 Dec; 223(3):310-4. PubMed ID: 23558296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the integrated fish endocrine disruptor test-Part B: Implementation of thyroid-related endpoints.
    Gölz L; Pannetier P; Fagundes T; Knörr S; Behnstedt L; Coordes S; Matthiessen P; Morthorst J; Vergauwen L; Knapen D; Holbech H; Braunbeck T; Baumann L
    Integr Environ Assess Manag; 2024 May; 20(3):830-845. PubMed ID: 37578010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.